gallbladder disease and semaglutide Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal side-effects, while important serious warnings include pancreatitis, disease, dehydration-related acute kidney injury GLP-1 Medications: What You Need

Semaglutide should not be taken by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)

Weight loss injections, including glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (Zepbound), have become increasingly popular for chronic weight management

Whole grains, fruits, nuts, and seeds are also excellent fiber sources

While there are studies on Ozempic and GLP-1 in mouse models, and they show potential metabolic and reproductive benefits- Ozempic has not been studied in infertile women as a fertility treatment